PRMT5-mediated arginine methylation of FXR1 is essential for RNA binding in cancer cells
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkae319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Anitha Vijayakumar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC 29425, USA. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, RNA-Binding Proteins, Arginine, Cell Proliferation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDCR NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Emerging evidence indicates that arginine methylation promotes the stability of arginine-glycine-rich (RGG) motif-containing RNA-binding proteins (RBPs) and regulates gene expression. Here, we report that post-translational modification of FXR1 enhances the binding with mRNAs and is involved in cancer cell growth and proliferation. Independent point mutations in arginine residues of FXR1’s nuclear export signal (R386 and R388) and RGG (R453, R455 and R459) domains prevent it from binding to RNAs that form G-quadruplex (G4) RNA structures. Disruption of G4-RNA structures by lithium chloride failed to bind with FXR1, indicating its preference for G4-RNA structure containing mRNAs. Furthermore, loss-of-function of PRMT5 inhibited FXR1 methylation both in vivo and in vitro, affecting FXR1 protein stability, inhibiting RNA-binding activity and cancer cell growth and proliferation. Finally, the enhanced crosslinking and immunoprecipitation (eCLIP) analyses reveal that FXR1 binds with the G4-enriched mRNA targets such as AHNAK, MAP1B, AHNAK2, HUWE1, DYNC1H1 and UBR4 and controls its mRNA expression in cancer cells. Our findings suggest that PRMT5-mediated FXR1 methylation is required for RNA/G4-RNA binding, which promotes gene expression in cancer cells. Thus, FXR1’s structural characteristics and affinity for RNAs preferentially G4 regions provide new insights into the molecular mechanism of FXR1 in oral cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC 29425, USA.
- Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico, Albuquerque, NM 87131, USA.
- Department of Neuroscience, Medical University of South Carolina, Charleston, SC 29425, USA.
- Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425, USA.
ORCID-Profile: Joseph Karam, Philip H Howe, Viswanathan Palanisamy
Förderung
- NCI NIH HHS
- NIDCR NIH HHS
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Vijayakumar, A., Majumder, M., Yin, S., Brobbey, C., Karam, J., Howley, B., Howe, P. H., Berto, S., Madan, L. K., Gan, W., & Palanisamy, V. (2024). PRMT5-mediated arginine methylation of FXR1 is essential for RNA binding in cancer cells. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae319
Vancouver
Vijayakumar A, Majumder M, Yin S, Brobbey C, Karam J, Howley B, et al. PRMT5-mediated arginine methylation of FXR1 is essential for RNA binding in cancer cells. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae319
BibTeX
@article{Vijayakumar2024,
author = {Vijayakumar, Anitha and Majumder, Mrinmoyee and Yin, Shasha and Brobbey, Charles and Karam, Joseph and Howley, Breege and Howe, Philip H and Berto, Stefano and Madan, Lalima K and Gan, Wenjian and Palanisamy, Viswanathan},
title = {PRMT5-mediated arginine methylation of FXR1 is essential for RNA binding in cancer cells},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkae319}
}
EUVIMED